Financial Performance - The company's revenue for Q3 2021 reached ¥859,501,122.47, representing a 139.25% increase compared to the same period last year[4] - Net profit attributable to shareholders was ¥93,795,900.53, a 100.61% increase year-over-year[4] - The basic earnings per share for the period was ¥0.78, reflecting a 136.86% increase compared to the previous year[4] - Total operating revenue for the first three quarters of 2021 reached ¥1,981,527,899.01, a significant increase from ¥1,203,055,132.21 in the same period of 2020, representing a growth of approximately 64.5%[21] - Net profit for the first three quarters of 2021 was ¥200,136,686.39, up from ¥193,393,604.68 in the same period of 2020, reflecting a growth of approximately 3.8%[23] - Basic earnings per share for the first three quarters of 2021 were ¥1.67, compared to ¥1.61 in the same period of 2020, representing an increase of about 3.7%[24] Research and Development - Research and development expenses totaled ¥34,963,498.51 for the quarter, a 75.98% increase year-over-year[5] - The company plans to continue increasing its R&D investment to enhance product development and market competitiveness[10] - Research and development expenses for the first three quarters of 2021 were ¥86,214,492.29, compared to ¥54,380,759.28 in the same period of 2020, indicating an increase of about 58.6%[23] Assets and Liabilities - The total assets of the company at the end of the reporting period were ¥2,381,744,395.84, a 4.18% increase from the end of the previous year[5] - Total assets as of September 30, 2021, amounted to RMB 2,381,744,395.84, an increase from RMB 2,286,240,131.56 as of December 31, 2020, reflecting a growth of approximately 4.2%[15] - The total liabilities decreased from ¥62,518,983.89 as of December 31, 2020, to ¥56,286,561.78 as of September 30, 2021, a reduction of about 10%[18] - The total equity attributable to shareholders increased from ¥2,223,721,147.67 at the end of 2020 to ¥2,325,457,834.06 by September 30, 2021, marking an increase of approximately 4.6%[18] Cash Flow - The net cash flow from operating activities was negative at -¥37,593,051.77, a decline of 116.17% compared to the same period last year[4] - The cash inflow from operating activities for the first three quarters of 2021 was approximately ¥2.43 billion, compared to ¥1.48 billion in the same period of 2020, representing an increase of about 64.5%[27] - The cash inflow from investment activities was approximately ¥66.14 million in 2021, down from ¥760.12 million in 2020, indicating a decrease of about 91.3%[28] - The cash outflow from financing activities was approximately ¥98.40 million in 2021, compared to ¥154.99 million in 2020, showing a decrease of about 36.5%[28] - The total cash and cash equivalents at the end of Q3 2021 were approximately ¥168.18 million, down from ¥340.74 million at the end of Q3 2020, a decrease of about 50.7%[28] Shareholder Information - The company reported a total of 5,695 common stock shareholders at the end of the reporting period[12] - The largest shareholder, Longyan Excellent Investment Co., Ltd., holds 58,500,000 shares, representing 48.75% of total shares[12] - The second-largest shareholder, Hong Kong Excellent International Holdings Limited, owns 31,500,000 shares, accounting for 26.25%[12] Operational Insights - The company experienced a delay in shipping that affected revenue recognition, with a shipment of 11,700 tons of biodiesel postponed to October 8[5] - The company's gross profit margin improved due to increased production capacity and higher sales prices of biodiesel products[10] - There are no significant reminders or additional important information regarding the company's operational situation during the reporting period[14] - The company has not disclosed any significant new product developments or market expansion strategies in this report[14]
卓越新能(688196) - 2021 Q3 - 季度财报